DNA Polymerase Market Trends, Developments, Growth, Opportunities and Forecasts 2022 to 2030
The global DNA polymerase market size is expected to reach USD 568.3 million by 2030 at a CAGR of 6.4%
NEW YORK CITY, NEW YORK, UNITED STATES, August 4, 2022 /EINPresswire.com/ — The globe DNA polymerase market According to the latest report by Reports and Data, the size is expected to reach US$568.3 million in 2030, registering a CAGR of 6.4% in sales during the forecast period. The increase in the number of researches based on genetic disorders and the increasing adoption of Taq DNA polymerase for thermal tolerance and high efficiency are expected to drive the revenue growth of the market over the forecast period. Increasing demand for DNA polymerase in polymerase chain reactions is expected to fuel the growth of DNA polymerase market in the near future. An increasing body of research related to the diagnosis of human disease has led to increased introduction of DNA polymerase into laboratories. Eukaryotic DNA polymerase is widely used in research laboratories due to its ready availability from eukaryotic model organisms, which can be genetically manipulated to obtain optimal strains of the enzyme. The thermostability and robustness of Taq DNA polymerase make it a key component in polymerase chain reactions that involve the denaturation of sample DNA at high temperatures, increasing the demand for Taq DNA polymerase. This is expected to drive the revenue growth of the market in the near future. The increasing demand for Taq DNA polymerase is expected to drive the revenue growth of the market due to its heat resistance and shelf life properties. Furthermore, increasing adoption of DNA polymerase due to its exonuclease proofreading activity has led to increased demand for DNA polymerase, which is expected to drive the revenue growth of the market.
Access a free sample PDF copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/5010
Leading Players: Sigma-Aldrich Solutions, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Yeasen Biotechnology (Shanghai) Co., Ltd., GENAXXON Bioscience, Promega Corporation, Cytiva Lifesciences, SBS Genetech Co., Ltd., BDI Biotech and GenTegra LLC.
Some key highlights from the report
The biotechnology segment is expected to account for the largest market share during the forecast period. The growing use of DNA polymerases in in vivo DNA manipulation and disease diagnosis is driving growth of the segment.
The DNA replication segment is projected to account for the largest revenue share in the global DNA polymerase market between 2022 and 2030. Increasing demand for DNA polymerase in DNA replication in pharmaceutical and biotechnology industries is driving segment revenue growth. Increasing demand for custom DNA polymerases also increases demand for DNA polymerases, which is expected to fuel the growth of the segment.
The DNA polymerase market in Asia Pacific is expected to account for the largest revenue share in the global market during the forecast period. The rapid growth of the pharmaceutical industry, in which DNA polymerase plays an essential role, is expected to drive the revenue growth of the market. Rapid improvements in DNA polymerase according to the need of specific reactions is another factor expected to boost revenue growth of DNA polymerase market.
In December 2021, SBS Genetech Co., Ltd. announced a price reduction for their mutant proteinase K to $40/g. Mutant Proteinase K is one of the best-selling products from SBS Genetech Co., Ltd., one of the first Chinese companies to provide scientific solutions for life scientists and researchers. This announcement is expected to increase demand for mutant proteinase K, whose activity has been increased by 30% as a result of the development of the technology.
To learn more about the report @ https://www.reportsanddata.com/report-detail/dna-polymerase-market
Segments Covered in the Report:
For the purposes of this report, reports and data have segmented the global DNA Polymerase market based on type, material, end-users, application and region:
Origin Outlook (Revenue, $M; 2019-2030)
Prokaryotic DNA polymerase
Eukaryotic DNA polymerase
End Use Outlook (Revenue, $M; 2019-2030)
hospitals and diagnostic centers
Bid Outlook (Revenue, $M; 2019-2030)
Talk to Customization Analyst @ https://www.reportsanddata.com/request-customization-form/5010
North America (USA, Canada, Mexico)
Europe (Italy, UK, Germany, France, Rest of EU)
Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
Middle East and Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)
Take a look at other related reports:
Aluminum Nitride [email protected] https://www.reportsanddata.com/report-detail/aluminum-nitride-market
Cellulosic Gum CMC [email protected] https://www.reportsanddata.com/report-detail/cellulose-gum-cmc-market
Automotive Silicone [email protected] https://www.reportsanddata.com/report-detail/automotive-silicone-market
Reports and Data is a market research and consulting company offering syndicated research reports, custom research reports and consulting services. Our solutions are solely focused on your purpose of locating, targeting and analyzing demographic and cross-industry shifts in consumer behavior and helping customers make smarter business decisions. We offer market research studies that ensure relevant and fact-based research across multiple industries including healthcare, touchpoints, chemicals, products and energy. We are constantly updating our research offerings to ensure our clients are up to date with the latest trends in the market. Reports and Data has a strong base of experienced analysts from different disciplines. Our industry experience and ability to develop a concrete solution to any research problem provides our clients with an opportunity to gain an advantage over their respective competitors.